https://www.openbell.ai/ 2026-10-19T14:39:55.230Z hourly 1.0 https://www.openbell.ai/support 2026-10-19T14:39:55.230Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-19T14:39:55.230Z monthly 0.5 https://www.openbell.ai/terms 2026-10-19T14:39:55.230Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-19T14:39:55.230Z hourly 0.8 https://www.openbell.ai/news/CHDN:1792420744831 2026-10-19T14:39:04.831Z daily 0.9 https://cdn.brandfetch.io/CHDN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Overweight on Churchill Downs, Raises Price Target to $120 Wells Fargo analyst Trey Bowers has maintained an Overweight rating on Churchill Downs (NASDAQ: CHDN) and increased the price target from $117 to $120. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/MRNA:1792420674858 2026-10-19T14:37:54.858Z daily 0.9 https://cdn.brandfetch.io/MRNA/w/400/h/400?c=1idopYfmtR7ZKg8QMud What's Going On With Moderna Stock Monday? Moderna Inc. (NASDAQ: MRNA) shares rose 4.40% to $227.61 as investors anticipate detailed Phase 3 melanoma data to be presented at the ESMO Congress on October 24. Bank of America increased its price target for the stock from $200 to $220 while maintaining a Neutral rating. The stock is rebounding after a nearly 10% drop from its 52-week high of $242.29, attributed to profit-taking following a 600% increase this year. Moderna is set to report its third-quarter results on November 6. https://www.openbell.ai/news/ANRO:1792420647176 2026-10-19T14:37:27.176Z daily 0.9 https://cdn.brandfetch.io/ANRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $60 HC Wainwright & Co. analyst Patrick R. Trucchio has maintained a Buy rating on Alto Neuroscience (NYSE: ANRO) and raised the price target from $55 to $60. This adjustment reflects a positive outlook for the company's performance. https://www.openbell.ai/news/AMD:1792420571618 2026-10-19T14:36:11.618Z daily 0.9 https://cdn.brandfetch.io/AMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of semiconductor and chip companies are trading higher as the sector rebounds from last week's weakness, with CoreWeave, the bellwether, rising on a Goldman Sachs upgrade. The Philadelphia Semiconductor Index is expected to end its longest losing streak since the 2008 financial crisis. openbell Financial News https://www.openbell.ai/news/IRON:1792420489581 2026-10-19T14:34:49.581Z daily 0.9 https://cdn.brandfetch.io/IRON/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cantor Fitzgerald Maintains Overweight on Disc Medicine, Raises Price Target to $170 Cantor Fitzgerald analyst Kristen Kluska has maintained an Overweight rating on Disc Medicine (NASDAQ: IRON) and raised the price target from $125 to $170. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/HII:1792420330521 2026-10-19T14:32:10.521Z daily 0.9 https://cdn.brandfetch.io/HII/w/400/h/400?c=1idopYfmtR7ZKg8QMud HII’s Ingalls Shipbuilding Division Receives $99M U.S. Navy Contract Modification To Carry Out See Trials For Zumwalt-Class Destroyer Lyndon B. Johnson HII's Ingalls Shipbuilding division has secured a $99 million contract modification from the U.S. Navy for conducting sea trials for the Zumwalt-class destroyer Lyndon B. Johnson (DDG 1002). The destroyer arrived at Ingalls in January 2022 for the installation, activation, and testing of its combat systems. https://www.openbell.ai/news/URGN:1792420269100 2026-10-19T14:31:09.100Z daily 0.9 https://cdn.brandfetch.io/URGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $75 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on UroGen Pharma (NASDAQ: URGN) and maintained a price target of $75 for the stock. No additional financial figures or strategic changes were mentioned in the article. https://www.openbell.ai/news/SPCX:1792420222810 2026-10-19T14:30:22.810Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Elon-Musk-is-the-founder--CEO--and-Chief.jpg?width=250&height=187 SpaceX Stock Moves Higher: What's Going On? SpaceX (NASDAQ: SPCX) shares rose 2.92% to $150.29 ahead of its third-quarter earnings report scheduled for October 20. Analysts expect the company to report $12.74 billion in revenue, a 63% increase from the previous quarter's $7.8 billion. In the second quarter, SpaceX's net loss decreased to $541 million from $1.0 billion, while adjusted EBITDA nearly tripled to $3.5 billion. RBC Capital maintains an Outperform rating with a price target of $225, citing positive momentum and potential merger discussions with Tesla. https://www.openbell.ai/news/BWAY:1792420125864 2026-10-19T14:28:45.864Z daily 0.9 https://cdn.brandfetch.io/BWAY/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $19 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on BrainsWay (NASDAQ: BWAY) and maintained a price target of $19 for the stock. This endorsement suggests confidence in the company's future performance. https://www.openbell.ai/news/MAR:1792420088556 2026-10-19T14:28:08.556Z daily 0.9 https://cdn.brandfetch.io/MAR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Evercore ISI Group Maintains Outperform on Marriott International, Raises Price Target to $420 Evercore ISI Group analyst Duane Pfennigwerth has maintained an 'Outperform' rating on Marriott International (NASDAQ: MAR) and raised the price target from $400 to $420. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/DDOG:1792420072313 2026-10-19T14:27:52.313Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/DataDog.jpg?width=250&height=187 Why Is Datadog Stock Surging Monday? Datadog Inc. (NASDAQ: DDOG) saw its stock rise over 4% to $257.59 following an upgrade from Bernstein, which raised its price target from $237 to $350, citing stronger growth opportunities in artificial intelligence. The stock has gained 66.60% over the past year and is trading above key long-term moving averages, although it remains below its 20-day SMA of $269.78. Analysts expect Datadog's upcoming earnings report on November 4 to show earnings of 65 cents per share and revenue of $1.14 billion, up from 55 cents and approximately $890 million a year ago, respectively. https://www.openbell.ai/news/UTHR:1792420069802 2026-10-19T14:27:49.802Z daily 0.9 https://cdn.brandfetch.io/UTHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Leerink Partners Maintains Outperform on United Therapeutics, Raises Price Target to $725 Leerink Partners analyst Roanna Ruiz has maintained an 'Outperform' rating on United Therapeutics (NASDAQ: UTHR) and increased the price target from $685 to $725. https://www.openbell.ai/news/VSTM:1792419931893 2026-10-19T14:25:31.893Z daily 0.9 https://cdn.brandfetch.io/VSTM/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Reiterates Buy on Verastem, Maintains $24 Price Target BTIG analyst Jeet Mukherjee has reiterated a Buy rating on Verastem (NASDAQ: VSTM) and maintained a price target of $24 for the stock. This endorsement suggests confidence in the company's future performance. https://www.openbell.ai/news/UROY:1792419833212 2026-10-19T14:23:53.212Z daily 0.9 https://cdn.brandfetch.io/UROY/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Uranium Royalty, Maintains $4.5 Price Target HC Wainwright & Co. analyst Heiko F. Ihle has reiterated a Buy rating on Uranium Royalty (NASDAQ: UROY) and has maintained a price target of $4.5 for the stock. https://www.openbell.ai/news/CYTK:1792419745865 2026-10-19T14:22:25.865Z daily 0.9 https://cdn.brandfetch.io/CYTK/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Cytokinetics, Maintains $140 Price Target HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on Cytokinetics (NASDAQ: CYTK) and maintained a price target of $140 for the stock. https://www.openbell.ai/news/CHOW:1792419742676 2026-10-19T14:22:22.676Z daily 0.9 https://cdn.brandfetch.io/CHOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud ChowChow Cloud International Shares Halted On Circuit Breaker To The Upside, Stock Now Up 109.72% openbell Financial News https://www.openbell.ai/news/SLN:1792419645237 2026-10-19T14:20:45.237Z daily 0.9 https://cdn.brandfetch.io/SLN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Silence Therapeutics shares are trading higher after the company announced that it will be acquired by Merck KGaA, Darmstadt, Germany, in an all-cash transaction with an enterprise value of $1.1 billion and an equity value of approximately $1.3 billion. openbell Financial News https://www.openbell.ai/news/WMB:1792419526051 2026-10-19T14:18:46.051Z daily 0.9 https://cdn.brandfetch.io/WMB/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Trump Administration Commits Up To $42M To Revive Stalled Northeast Natural Gas Pipeline' - Fox Business The Trump administration has committed up to $42 million to revive a stalled natural gas pipeline in the Northeast. This funding aims to support the construction and operation of the pipeline, which is expected to enhance energy supply in the region. The announcement may positively impact the stock performance of Williams Companies (WMB), which is involved in the pipeline's development. https://www.openbell.ai/news/PLTR:1792419264435 2026-10-19T14:14:24.435Z daily 0.9 https://cdn.brandfetch.io/PLTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Palantir Technologies Stock Gaining Monday? Palantir Technologies Inc. (NASDAQ: PLTR) saw its stock rise nearly 3% on Monday, closing at $191.11, following a rebound in technology stocks and renewed interest in artificial intelligence. The company announced a partnership with Knox Systems to expedite software deployment for U.S. government agencies, focusing on secure applications in FedRAMP and Impact Level 5 environments. Despite a recent 7.2% drop due to concerns over AI-related debt and insider stock sales, analysts maintain a Buy consensus rating with price targets ranging from $210.47 to $265. https://www.openbell.ai/news/PLTR:1792419212228 2026-10-19T14:13:32.228Z daily 0.9 https://cdn.brandfetch.io/PLTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Palantir Technologies Stock Gaining Monday? Palantir Technologies Inc. (NASDAQ: PLTR) saw its stock rise nearly 3% to $191.11 on Monday, following a rebound in technology stocks and a partnership announcement with Knox Systems aimed at accelerating software deployment for U.S. government agencies. The partnership focuses on enhancing secure software delivery for federal customers, particularly in environments requiring strict security controls. Despite a recent decline of 7.2% due to concerns over AI-related debt and insider stock sales, analysts maintain a Buy consensus rating with price forecasts ranging from $210.47 to $265. https://www.openbell.ai/news/PLTR:1792419204429 2026-10-19T14:13:24.429Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Apex--North-Carolina---October-27-2025-P.jpg?width=250&height=187 Why Is Palantir Technologies Stock Gaining Monday? Palantir Technologies Inc. (NASDAQ: PLTR) saw its stock rise nearly 3% on Monday, reaching $191.11, following a rebound in technology stocks and renewed interest in artificial intelligence. The company announced a partnership with Knox Systems aimed at accelerating software deployment for U.S. government agencies, which is expected to enhance access to critical technology. Despite a recent 7.2% drop on Friday due to concerns over AI-related debt and insider stock sales, analysts maintain a Buy consensus rating with price forecasts ranging from $210.47 to $265. https://www.openbell.ai/news/ASST:1792419147090 2026-10-19T14:12:27.090Z daily 0.9 https://cdn.brandfetch.io/ASST/w/400/h/400?c=1idopYfmtR7ZKg8QMud Strive shares are trading higher after the company announced that during the period from October 12, 2026 through October 16, 2026, it purchased 4,045 bitcoin at an average price of approximately $82,803 per bitcoin. openbell Financial News https://www.openbell.ai/news/PLTR:1792419051967 2026-10-19T14:10:51.967Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Apex--North-Carolina---October-27-2025-P.jpg?width=250&height=187 Why Is Palantir Technologies Stock Gaining Monday? Palantir Technologies Inc. (NASDAQ: PLTR) saw its stock rise nearly 3% to $191.11 on Monday, following a rebound in technology stocks and renewed interest in artificial intelligence. The company announced a partnership with Knox Systems to enhance software deployment for U.S. government agencies, aiming to expedite the delivery of mission-critical applications while adhering to federal security standards. Despite a 7.2% drop on Friday due to concerns over AI-related debt and insider sales, analysts maintain a Buy consensus rating with price forecasts ranging from $210.47 to $265. https://www.openbell.ai/news/PLTR:1792419041990 2026-10-19T14:10:41.990Z daily 0.9 https://cdn.brandfetch.io/PLTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Palantir Technologies Stock Gaining Monday? Palantir Technologies Inc. (NASDAQ: PLTR) saw its stock rise nearly 3% to $191.11 on Monday, following a rebound in technology stocks and renewed interest in artificial intelligence. The company announced a partnership with Knox Systems aimed at accelerating software deployment for U.S. government agencies, which is expected to enhance access to critical technology. Despite a recent drop of 7.2% due to concerns over AI-related debt and insider sales, analysts maintain a Buy consensus rating with price forecasts ranging from $210.47 to $265. https://www.openbell.ai/news/PBLS:1792419022574 2026-10-19T14:10:22.574Z daily 0.9 https://cdn.brandfetch.io/PBLS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Parabilis Medicines shares are trading higher after the company announced it will present updated clinical data for Zolucatetide in patients with desmoid tumors at ESMO Congress 2026. openbell Financial News https://www.openbell.ai/news/PLTR:1792419006461 2026-10-19T14:10:06.461Z daily 0.9 https://cdn.brandfetch.io/PLTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Palantir Technologies Stock Gaining Monday? Palantir Technologies Inc. (NASDAQ: PLTR) stock increased by nearly 3% on Monday, recovering from a previous decline, as technology stocks rebounded. The company announced a partnership with Knox Systems to enhance software deployment for U.S. government agencies, focusing on compliance with federal security requirements. Despite a recent drop of 7.2% to $186.03 due to concerns over AI-related debt and insider sales, analysts maintain a Buy consensus rating with price forecasts ranging from $210.47 to $265. https://www.openbell.ai/news/PLTR:1792418987062 2026-10-19T14:09:47.062Z daily 0.9 https://cdn.brandfetch.io/PLTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Palantir Technologies Stock Gaining Monday? Palantir Technologies Inc. (NASDAQ: PLTR) saw its stock rise nearly 3% on Monday, closing at $191.11, following a rebound in technology stocks and renewed interest in artificial intelligence. The company announced a partnership with Knox Systems to enhance software deployment for U.S. government agencies, aiming to expedite the delivery of mission-critical applications while adhering to federal security requirements. Despite a recent drop of 7.2% due to concerns over AI-related debt and insider stock sales, analysts maintain a Buy consensus rating with price forecasts ranging from $210.47 to $265. https://www.openbell.ai/news/MANE:1792418958066 2026-10-19T14:09:18.066Z daily 0.9 https://cdn.brandfetch.io/MANE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Veradermics shares are trading higher after the company announced that its VDPHL01 met all primary and secondary endpoints. Also, Needham maintained its Buy rating on the stock and raised its price target from $164 to $172. openbell Financial News https://www.openbell.ai/news/PLTR:1792418852667 2026-10-19T14:07:32.667Z daily 0.9 https://cdn.brandfetch.io/PLTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Palantir Technologies Stock Gaining Monday? Palantir Technologies Inc. (NASDAQ: PLTR) saw its stock rise nearly 3% to $191.11 on Monday, following a rebound in technology stocks and renewed interest in artificial intelligence. The company announced a partnership with Knox Systems aimed at accelerating software deployment for U.S. government agencies, which is expected to enhance the delivery of mission-critical applications while meeting federal security requirements. Despite a recent decline of 7.2% on Friday due to concerns over AI-related debt and insider stock sales, analysts maintain a Buy consensus rating with price forecasts ranging from $210.47 to $265. https://www.openbell.ai/news/SLN:1792418709359 2026-10-19T14:05:09.359Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Display-Of-Stock-Market-Quotes.jpg?width=250&height=187 Silence Therapeutics, Disc Medicine, Veradermics And Other Big Stocks Moving Higher On Monday Silence Therapeutics PLC (NASDAQ: SLN) shares surged 125.7% to $19.60 after the company announced its acquisition by Merck KGaA for $20 per ADS, valuing the enterprise at $1.1 billion and the equity at approximately $1.3 billion. Despite a mixed day for U.S. stocks, other companies like Disc Medicine Inc (NASDAQ: IRON) and Veradermics Inc (NYSE: MANE) also saw significant gains, with Disc Medicine rising 24.7% to $70.90 following positive trial results, and Veradermics increasing 5.7% to $115.00 due to successful clinical trial outcomes. https://www.openbell.ai/news/GOOGL:1792418564376 2026-10-19T14:02:44.376Z daily 0.9 https://cdn.brandfetch.io/GOOGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud "Anthropic Readies Model That Reads Users' Intentions Better" - The Information Anthropic is preparing to launch a new AI model designed to better understand user intentions. This advancement aims to enhance user interaction and improve the overall effectiveness of AI applications. The move is seen as a strategic effort to compete in the rapidly evolving AI market, particularly against major players like Google (GOOGL). https://www.openbell.ai/news/VFS:1792418535262 2026-10-19T14:02:15.262Z daily 0.9 https://cdn.brandfetch.io/VFS/w/400/h/400?c=1idopYfmtR7ZKg8QMud VinFast Auto shares are trading lower after the company reported worse-than-expected Q2 EPS results. openbell Financial News https://www.openbell.ai/news/RIG:1792417973231 2026-10-19T13:52:53.231Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Stuttgart--Germany---05-22-2022-Person-H.jpg?width=250&height=187 What's Going On With Transocean Stock Today? Transocean Ltd (NYSE: RIG) secured two contracts for ultra-deepwater drillships in the U.S. Gulf, adding approximately $550 million to its firm contract backlog, which now exceeds $8 billion. The contracts involve the Deepwater Proteus and Deepwater Conqueror drillships, with operations set to begin in 2027. On the stock market, Transocean shares rose by nearly 2% to $5.74, reflecting a 70.82% increase over the past year. Analysts expect the company to report earnings of 3 cents per share and revenue of $937.6 million in its upcoming earnings report on November 2. https://www.openbell.ai/news/ETHUSD:1792417735338 2026-10-19T13:48:55.338Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/The-Bitmine-Immersion-Trade.jpg?width=250&height=187 Bitmine Buys 12,535 Ethereum as Tom Lee Calls Tech, Crypto a ‘Coiled Spring’ Bitmine Immersion Technologies (NYSE: BMNR) purchased 12,535 Ethereum last week, increasing its total Ethereum holdings to approximately 6.04 million tokens, valued at $2,365 each, which is 4.9% of Ethereum's total supply. The company's total assets, including crypto and cash, now amount to $15.1 billion. Bitmine has consistently acquired Ethereum weekly since launching its treasury strategy in June 2025, and it is currently the largest Ethereum treasury globally. Despite a recent 7% decline in BMNR shares, the stock rose 1.5% in premarket trading. https://www.openbell.ai/news/WETH:1792417625957 2026-10-19T13:47:05.957Z daily 0.9 https://cdn.brandfetch.io/WETH/w/400/h/400?c=1idopYfmtR7ZKg8QMud WeTouch Technology Inks Agreement With Hefei Aoweixun Electronic Technology To Jointly Produce Touch Sensing, Human-Machine Interaction, Intelligent Interface Tools for Robotic Systems WeTouch Technology Inc. (NASDAQ: WETH) has signed a strategic cooperation agreement with Hefei Aoweixun Electronic Technology Co., Ltd. The partnership aims to jointly develop advanced touch sensing, human-machine interaction, and intelligent interface tools specifically for robotic systems. https://www.openbell.ai/news/ELF:1792417574017 2026-10-19T13:46:14.017Z daily 0.9 https://cdn.brandfetch.io/ELF/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jefferies Maintains Buy on e.l.f. Beauty, Raises Price Target to $132 Jefferies analyst Sydney Wagner has maintained a 'Buy' rating on e.l.f. Beauty (NYSE: ELF) and increased the price target from $100 to $132. This adjustment reflects positive expectations for the company's performance in the market. https://www.openbell.ai/news/FITB:1792417509395 2026-10-19T13:45:09.395Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Walmart-Misses-Nasdaq-100--LULU-Slumps.jpg?width=250&height=187 Nasdaq Surges Over 1%; Fifth Third Bancorp Earnings Top Views On Monday, the Nasdaq Composite rose by 1.09% to 26,425.68, while the Dow fell by 0.12% to 51,940.39. Fifth Third Bancorp reported third-quarter earnings of $1.13 per share, surpassing the analyst estimate of 96 cents, although its quarterly sales of $3.279 billion fell short of the expected $3.339 billion. In sector performance, information technology stocks increased by 1.4%, while utilities stocks declined by 0.8%. https://www.openbell.ai/news/COSM:1792416816123 2026-10-19T13:33:36.123Z daily 0.9 https://cdn.brandfetch.io/COSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cosmos Health Expects Q4 Sales Of ~$15M, Gross Profit Of ~$10.5M With Gross Margin Of ~70% Cosmos Health anticipates Q4 sales of approximately $15 million, with a gross profit of about $10.5 million, resulting in a gross margin of around 70%. The company expects subscription revenue to reach approximately $11.5 million, driven by 14,624 online checkout orders, a 34% increase from the previous count. Active subscriptions have risen to 8,940, marking a 42% growth, with expectations to exceed 40,000 by year-end. https://www.openbell.ai/news/HINC:1792416600504 2026-10-19T13:30:00.504Z daily 0.9 https://cdn.brandfetch.io/HINC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halt status updated at 9:30:00 AM ET: Quotation Resumption: IPO security released for quotation openbell Financial News https://www.openbell.ai/news/OXY:1792416595906 2026-10-19T13:29:55.906Z daily 0.9 https://cdn.brandfetch.io/OXY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Stephens & Co. Maintains Overweight on Occidental Petroleum, Raises Price Target to $80 Stephens & Co. analyst Mike Scialla has maintained an Overweight rating on Occidental Petroleum (NYSE: OXY) and increased the price target from $78 to $80. https://www.openbell.ai/news/QNT:1792416527874 2026-10-19T13:28:47.874Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Stuttgart--Germany---05-13-2026-In-This-.jpg?width=250&height=187 Quantinuum Stock Climbs as Helios Hits 99.9995% Logical Fidelity, Nearing 2029 Target Quantinuum Inc. (NASDAQ: QNT) shares rose 5.34% to $38.49 following the announcement of a world-record quantum error-correction result from its Helios computer, achieving a logical fidelity of 99.9995%, which translates to five errors per million operations. This performance is ten times better than its previous record and significantly surpasses the best results from other hardware types. The company believes this advancement positions it closer to its goal of developing a fault-tolerant quantum computer by 2029, potentially requiring fewer qubits than competitors. https://www.openbell.ai/news/TRV:1792416514888 2026-10-19T13:28:34.888Z daily 0.9 https://cdn.brandfetch.io/TRV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Travelers Companies, Raises Price Target to $435 Truist Securities analyst Mark Hughes has maintained a Buy rating on Travelers Companies (NYSE: TRV) and increased the price target from $425 to $435. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/CVE:1792416424664 2026-10-19T13:27:04.664Z daily 0.9 https://cdn.brandfetch.io/CVE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jefferies Maintains Buy on Cenovus Energy, Raises Price Target to C$54 Jefferies has reiterated a Buy rating on Cenovus Energy (TSX: CVE) and increased its price target from C$51 to C$54. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/RVMD:1792416404170 2026-10-19T13:26:44.170Z daily 0.9 https://cdn.brandfetch.io/RVMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Revolution Medicines, Raises Price Target to $241 Truist Securities analyst Gregory Renza has maintained a 'Buy' rating on Revolution Medicines (NASDAQ: RVMD) and raised the price target from $240 to $241. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/VRSN:1792416320728 2026-10-19T13:25:20.728Z daily 0.9 https://cdn.brandfetch.io/VRSN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wedbush Maintains Outperform on VeriSign, Raises Price Target to $351 Wedbush analyst Ygal Arounian has maintained an 'Outperform' rating on VeriSign (NASDAQ: VRSN) and raised the price target from $341 to $351. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/MSFT:1792416303480 2026-10-19T13:25:03.480Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Microsoft Expands Project Perception, CEO Satya Nadella Announces Microsoft is expanding its Project Perception initiative, as announced by CEO Satya Nadella. The expansion aims to enhance the company's capabilities in artificial intelligence and machine learning. Specific financial figures or strategic details regarding the expansion were not disclosed in the announcement. https://www.openbell.ai/news/CLF:1792416190671 2026-10-19T13:23:10.671Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Konskie--Poland---March-06--2025-Clevela.jpg?width=250&height=187 Steelmaker Cleveland-Cliffs Delivers Strongest Quarter in Three Years Cleveland-Cliffs Inc. reported adjusted earnings of 28 cents per share for the third quarter, surpassing analysts' expectations of 19 cents, while revenue of $5.612 billion fell short of the $5.724 billion consensus. The company anticipates fourth-quarter adjusted EBITDA to rise to approximately $715 million and aims to significantly reduce debt through stronger free cash flow. Additionally, Cleveland-Cliffs' stock rose by 15.68% to $14.02 in premarket trading following the announcement. https://www.openbell.ai/news/GPRO:1792416150419 2026-10-19T13:22:30.419Z daily 0.9 https://cdn.brandfetch.io/GPRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud GoPro Files Preliminary Proxy Statement; Proposed Merger With Starman Optical On Track; Companies Reaffirm Commitment To Completing Proposed Merger On Previously Announced Terms GoPro, Inc. has filed a preliminary proxy statement with the SEC regarding its proposed merger with Starman Optical, Inc., reaffirming its commitment to complete the merger on previously announced terms. The company also noted that a financial restatement reflects non-cash accounting adjustments. This merger is part of GoPro's strategic plans as it continues to navigate its financial landscape. https://www.openbell.ai/news/MVIS:1792416108967 2026-10-19T13:21:48.967Z daily 0.9 https://cdn.brandfetch.io/MVIS/w/400/h/400?c=1idopYfmtR7ZKg8QMud MicroVision Forms Alliance With Blue-Band To Provide Lidar-Powered Smart Infrastructure Services To Intelligence Transport System Market MicroVision, Inc. (NASDAQ: MVIS) has formed an exclusive strategic alliance with Blue-Band LLC to provide lidar-powered smart infrastructure solutions for the intelligent transportation system market. This partnership aims to enhance MicroVision's capabilities in the ITS sector and accelerate revenue generation by offering scalable and cost-effective solutions for transportation agencies and infrastructure operators. https://www.openbell.ai/news/CRWV:1792416092292 2026-10-19T13:21:32.292Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Coreweave.jpg?width=250&height=187 Goldman Sachs Upgrades CoreWeave Despite 15% Bond Yields as Stock Jumps 6% CoreWeave Inc. (NASDAQ: CRWV) shares rose 6% in premarket trading following an upgrade from Goldman Sachs, which moved the stock rating from Neutral to Buy. This upgrade comes despite a challenging bond market where yields on CoreWeave's debt have surged to nearly 15%. Analysts believe the company will manage its future expansion financing at reasonable costs, although concerns remain about its substantial borrowing needs, estimated at $35 billion, to support existing customer commitments.